Vasculitishttps://en.wikipedia.org/wiki/Vasculitis
Vasculitis jẹ ẹgbẹ awọn rudurudu ti o ba awọn ohun elo ẹjẹ jẹ nipasẹ igbona. Vasculitis le jẹ ipin nipasẹ idi, ipo, iru ọkọ tabi iwọn ọkọ. Awọn idanwo yàrá ati biopsy awọ le nilo lati wa awọn okunfa abẹlẹ. Awọn itọju ni gbogbogbo ni itọsọna si didaduro igbona naa ati didipa eto ajẹsara. Ni deede, awọn corticosteroids gẹgẹbi prednisone ni a lo.

○ Ayẹwo
Vasculitis ti o ni opin si awọ ara le ni ilọsiwaju ni akoko pupọ. Bibẹẹkọ, awọn idanwo ẹjẹ ati ito le ṣee ṣe lati rii awọn rudurudu eto-ara tabi autoimmune.

○ Itọju - Oògùn OTC
Ti vasculitis ba ni opin si awọ ara laisi ikọlu awọn ara miiran, ikunra sitẹriọdu le ṣee lo.
#OTC steroid ointment
☆ Ninu awọn abajade 2022 Stiftung Warentest lati Jẹmánì, itẹlọrun alabara pẹlu ModelDerm jẹ kekere diẹ ju pẹlu awọn ijumọsọrọ telemedicine isanwo.
  • Awọn rudurudu eto eto miiran (awọn aarun autoimmune) ti o kan vasculitis yẹ ki o yọkuro.
  • Eyi jẹ aworan aṣoju ti vasculitis ti ẹsẹ. Ayẹwo ito le ṣee ṣe lati ṣayẹwo fun awọn aiṣedeede ninu iṣẹ kidinrin.
  • Livedo vadculopathy
  • Purpura
  • Henoch schonlein purpura
References An aetiological & clinicopathological study on cutaneous vasculitis 22382191 
NIH
Of the 61 patients studied, hypersensitivity vasculitis (HSV) [23 (37.7%)] and Henoch Schonlein purpura (HSP) [16 (26.2%)] were the two most common forms. Systemic involvement was seen in 32 (52.45%) patients. Drugs were implicated in 12 (19.7%) cases, infections in 7 (11.4%) and connective tissue disorders in 4 (6.5%) cases. No association was seen between history of drug intake and tissue eosinophilia and also between histologically severe vasculitis and clinical severity.
 Leukocytoclastic Vasculitis 29489227 
NIH
Leukocytoclastic vasculitis jẹ iru iredodo awọ ara ti o kan awọn ohun elo ẹjẹ kekere ninu awọn ipele jinlẹ ti awọ ara. O le ṣẹlẹ laisi idi ti a mọ tabi ni asopọ si awọn akoran, awọn èèmọ, awọn arun autoimmune, tabi awọn oogun. Awọn ami ti o wọpọ pẹlu awọn aaye pupa tabi eleyi ti lori awọn ẹsẹ, ilowosi ti awọn ohun elo kekere, ati ni iwọn 30 ogorun awọn iṣẹlẹ, awọn ẹya ara miiran tun kan. Pupọ awọn ọran yọ kuro lori ara wọn laarin ọsẹ diẹ si awọn oṣu. Itọju yatọ si da lori bii o ṣe le, lati dinku awọn corticosteroids ẹnu si lilo awọn oogun miiran ti o dinku iredodo laisi awọn sitẹriọdu.
Leukocytoclastic vasculitis is a cutaneous, small-vessel vasculitis of the dermal capillaries and venules. This condition can be idiopathic or can be associated with infections, neoplasms, autoimmune disorders, and drugs. Key clinical features of leukocytoclastic vasculitis include palpable purpura on the lower extremity, small vessel involvement, and, in about 30 percent of individuals, extracutaneous involvement. Most cases of idiopathic cutaneous, small vessel vasculitis are self-limited with 90 percent of cases resolving in weeks to months of onset. Otherwise, treatment depends on the severity of disease and can range from an oral corticosteroid taper to various steroid-sparing immunosuppressive agents.